Sun Yat-sen University Cancer Center
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Orelabrutinib Combined With Zuberitamab in the Initial Treatment of MZL | BTKi; CD20; Initial MZL; Untreated MZL | Recruiting | Phase 2 | 2025-05-22 | NCT06985472 |